• Digestive and biliary disorders

Viokace Generic Name & Formulations

General Description

Lipase/protease/amylase: 10440Units/39150Units/39150Units; 20880Units/78300Units/78300Units; tabs.

Pharmacological Class

Pancreatic enzymes (porcine).

How Supplied



Viokace Indications


Treatment of exocrine pancreatic insufficiency in adults due to chronic pancreatitis or pancreatectomy, in combination with a proton pump inhibitor.

Viokace Dosage and Administration


Start at the lowest recommended dose and increase gradually. Individualize based on clinical symptoms, the degree of steatorrhea present, and the fat content of the diet. Swallow whole; do not crush or chew tabs. Take with meals and sufficient fluid. Do not let any drug remain in mouth. Initially 500 lipase units/kg per meal. Max: 2500 lipase units/kg per meal (or ≤10000 lipase units/kg/day), or <4000 lipase units/g fat ingested per day. See full labeling.


Not established.

Viokace Contraindications

Not Applicable

Viokace Boxed Warnings

Not Applicable

Viokace Warnings/Precautions


Not interchangeable with other pancrelipase products. Fibrosing colonopathy (with high doses); risk of stricture formation (monitor). Pork allergy. Potential viral transmission. Gout. Renal impairment. Hyperuricemia. Contents irritating to oral mucosa. Lactose intolerance. Pregnancy (Cat.C). Nursing mothers.

Viokace Pharmacokinetics

See Literature

Viokace Interactions

Not Applicable

Viokace Adverse Reactions

Adverse Reactions

Biliary tract stones, anal pruritus; allergic reactions.

Viokace Clinical Trials

See Literature

Viokace Note

Not Applicable

Viokace Patient Counseling

See Literature